Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Everest Medicines Announces First Chinese Patient Dosed in Global Phase 2b PALIZADE Trial of Zetomipzomib in Lupus Nephritis 2024-07-22 09:00
Innovent Announces the Second Phase 3 Trial of Mazdutide in Chinese Patients with Type 2 Diabetes Met Study Endpoints, and Plans to Submit NDA of Mazdutide to the NMPA 2024-07-22 08:00
DX&VX is on Track and Accelerating the Development of Oral Obesity Treatment 2024-07-18 21:00
BioWorld by Clarivate Celebrates Nine Wins at 2024 APEX Awards 2024-07-18 15:00
Getinge Interim Report April-June 2024: Higher sales, stronger margins and product launches with significant added value for customers 2024-07-18 14:33
Research Identifies Blind Spots That Affect Quality of Life Among People with HIV in Singapore 2024-07-18 13:45
PairX Bio Clinches Coveted Amgen Golden Ticket Award, as NSG BioLabs Deepens Efforts with Partners CapitaLand and Amgen to Boost Singapore's Biotech Ecosystem with Fourth Site and Extended Awards Programme 2024-07-18 10:00
China's Medical Device Market Value Hits $179B, 90th CMEF in Shenzhen to Feature a Plethora of Technological Products 2024-07-18 09:50
Everest Medicines Announces Official Acceptance Granted on NEFECON® Supplementary Application by China National Medical Products Administration 2024-07-18 08:00
ShiraTronics Unveils Data on their Neurostimulation System for Chronic Migraine 2024-07-16 22:10
Biosyngen's BRG01 enters Phase II clinical trial, a first-in-kind autologous EBV-Specific CAR-T Therapy for Solid Tumors on Recurrent/Metastatic Nasopharyngeal Carcinoma 2024-07-16 17:10
Smart Binhai, Glorious Competition! 2024 China Tianjin Binhai New Area Talent Innovation and Entrepreneurship Competition (Overseas Competition) Hong Kong SAR Division Finals to Begin Soon 2024-07-15 17:43
CPHI & PMEC Shenzhen 2024: Fostering New Opportunities in Asia and China's Greater Bay Area 2024-07-15 13:59
Everest Medicines Announces Positive Topline Results from Maintenance Period of Etrasimod Phase 3 Clinical Trial Conducted in Asia for the Treatment of Moderately-to-Severely Active Ulcerative Colitis 2024-07-15 13:44
Basecare Medical (2170. HK) revenue growth exceeds 50% in 2024H1 2024-07-15 12:17
MGI Tech Launches DNBSEQ-G400RS FluoXpert in the APAC Region at Medlab Asia & Asia Health 2024 2024-07-12 16:57
Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases 2024-07-12 16:53
CUHK identifies novel gut microbiome biomarkers to facilitate diagnosis of autism spectrum disorders 2024-07-11 18:36
Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL) 2024-07-11 14:24
Borsch Med Launches Ikigai Health Campaign with Zeria's Chondro Max 2024-07-11 12:13
1 9 10 11 12 13 229